Search Within

Hamza Hashmi

Formats
  1. Meeting Abstract (28)
  2. Journal Article (8)
  3. Research Letter (2)
  4. Review (2)
  5. Correspondence (1)
  6. Editorial (1)
Groups
  1. Center for Hematologic Malignancies (19)
  2. Department of Medicine (19)
  3. Hematologic Malignancies, Division of (19)
  4. Bone Marrow Transplant (18)
  5. Myeloma (18)
  6. Survivorship Research (18)

More Groups

People
  1. Sridevi Rajeeve (20)
  2. Saad Usmani (19)
  3. Heather Landau (18)
  4. Sham Mailankody (18)
  5. Alexander Lesokhin (17)
  6. Carlyn Rose Tan (17)

More People

Years
  1. 2025 (3)
  2. 2024 (39)
Publications
  1. Clinical Lymphoma, Myeloma and Leukemia (15)
  2. Blood (14)
  3. Blood Cancer Journal (3)
  4. European Journal of Haematology (2)
  5. Blood Advances (1)
  6. British Journal of Haematology (1)

More Publications

Publishers
  1. Elsevier Inc. (16)
  2. American Society of Hematology (15)
  3. John Wiley & Sons (3)
  4. Nature Publishing Group (3)
  5. Biomed Central Ltd (1)
  6. Frontiers Media S.A. (1)

More Publishers

Results (42)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Outcomes of older adults and frail patients receiving idecabtagene vicleucel: A CIBMTR study
    Research Letter

    Akhtar, O. S.; Oloyede, T.; Brazauskas, R.; Afrough, A.; Hashmi, H.; Sidana, S.; Ahmed, N.; Bye, M.; Hansen, D.; Ferreri, C.; more...
    Blood Advances (2025)

    Fulltext@MSK | Save
  • A real-world experience of efficacy and safety of belantamab mafodotin in relapsed refractory multiple myeloma
    Research Letter

    Dileo, R.; Mewawalla, P.; Babu, K.; Yin, Y.; Strouse, C.; Chen, E.; Shaikh, H.; Davis, J. A.; Green, K. M.; Alkharabsheh, O.; more...
    Blood Cancer Journal (2025)

    Fulltext@MSK | Save
  • Addition of elotuzumab to backbone treatment regimens for multiple myeloma: An updated meta-analysis of randomized clinical trials
    Journal Article

    Costa, B. A.; Costa, T. A.; Chagas, G. C. L.; Mouhieddine, T. H.; Richter, J.; Usmani, S. Z.; Mailankody, S.; Rajeeve, S.; Hashmi, H.
    Clinical Lymphoma, Myeloma and Leukemia (2025)

    Fulltext@MSK | Save
  • Genomic complexity correlates with the degree of marrow independence of malignant plasma cells in the context of extramedullary disease
    Meeting Abstract

    Maclachlan, K. H.; Garces, J. J.; Shekarkhand, T.; Rajeeve, S.; Hashmi, H.; Hassoun, H.; Hultcrantz, M.; Korde, N.; Tan, C. R.; Mailankody, S.; more...
    Blood (2024)

    Fulltext@MSK | Save
  • Evaluation of teclistamab in BCMA-directed therapy exposed versus naive in relapsed/refractory multiple myeloma
    Meeting Abstract

    Snyder, J.; Graf, K.; Davis, J. A.; McKenna, M.; Tiger, Y. K.; Laharwal, M. M.; Mewawalla, P.; Alkharabsheh, O.; Hashmi, H.; Shaikh, H.; more...
    Blood (2024)

    Fulltext@MSK | Save
  • A real-world analysis of the safety and efficacy of teclistamab for patients with relapsed/refractory multiple myeloma and baseline renal impairment
    Meeting Abstract

    Habib, A.; Khan, A. M.; Laharwal, M. M.; Mewawalla, P.; McKenna, M.; Tiger, Y. K.; Shaikh, H.; Strouse, C.; Green, K. M.; Davis, J. A.; more...
    Blood (2024)

    Fulltext@MSK | Save
  • Real-world efficacy outcomes of ciltacabtagene autoleucel in relapsed refractory multiple myeloma: A with the CARTITUDE-1 trial
    Meeting Abstract

    Kamboj, I.; Chang, D. R. Y.; Habib, A.; Vegel, A.; Struble, E.; Shaikh, H.; Strouse, C.; Davis, J. A.; Rashid, A.; Graf, K.; more...
    Blood (2024)

    Fulltext@MSK | Save
  • Real-world safety and early efficacy of talquetamab in patients with heavily-pretreated relapsed/refractory multiple myeloma
    Meeting Abstract

    Costa, B. A.; Tan, C. R.; Shekarkhand, T.; Firestone, R. S.; Jurgens, E. M.; Miller, K.; Lesokhin, A. M.; Shah, G. L.; Korde, N.; Rajeeve, S.; more...
    Blood (2024)

    Fulltext@MSK | Save
  • Defining the rates of cytokine release syndrome associated with talquetamab step-up doses
    Meeting Abstract

    Hamadeh, I. S.; Shekarkhand, T.; Rueda, C.; Firestone, R. S.; Wang, A. X.; Korde, N.; Hultcrantz, M.; Lesokhin, A. M.; Mailankody, S.; Hassoun, H.; more...
    Blood (2024)

    Fulltext@MSK | Save
  • Efficacy of daratumumab, pomalidomide and dexamethasone compared to daratumumab, carfilzomib and dexamethasone in high risk relapsed multiple myeloma: multicenter real-world experience
    Meeting Abstract

    Magee, G.; Mansour, R.; Chang, M. R.; Atrash, S.; Ahmed, N.; Mushtaq, M. U.; Ouchveridze, E.; Abdallah, A.; Paul, B.; Green, K. M.; more...
    Blood (2024)

    Fulltext@MSK | Save